Clinical Trial Imaging Market Scope And Analysis

  • Report Code : TIPHE100001201
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 186
Buy Now

Clinical Trial Imaging Market Analysis and Scope (2023 to 2028)

Buy Now


Clinical Trial Imaging Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.61 Billion
Market Size by 2028 US$ 2.48 Billion
Global CAGR (2022 - 2028) 7.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Modality
  • Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
By Offering
  • Operational Imaging Services
  • Imaging Software
  • Read Analysis Services
  • Trial Design and Consulting Services
By End User
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • eResearch Technology Inc
  • Calyx Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • BioTelemetry Inc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • Radiant Sage LLC
  • Industry Developments and Future Opportunities: 

    Various initiatives taken by key players operating in the global clinical trial imaging market are listed below:

    • In December 2022, Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) announced that the TCS ADD Connected Clinical Trials platform for decentralized trials, has won the India Pharma Award 2022 in the category, Excellence in Ancillary Pharma Services.
    • In October 2021, Medidata, a Dassault Systèmes company, announced that Rave Imaging, the company’s cloud-based, secure clinical trial imaging management platform, has reached a significant milestone, having supported more than 1,000 imaging studies. Rave Imaging, built on the Medidata Unified Platform, processes more than 100 million images per year. The technology provides real-time visibility into all imaging-related trial activities across all Rave Imaging trials to enhance study efficiency.

    Competitive Landscape and Key Companies:

    The clinical trial imaging market majorly consists of players such as eResearch Technology Inc, Calyx Inc, ICON PLC, VIDA Diagnostics Inc, WCG Clinical Inc, BioTelemetry Inc, Medical Metrics Inc, Medpace Holdings Inc, Radiant Sage LLC, and IXICO plc. The companies have been implementing various strategies that have helped their growth and, in turn, have brought about various changes in the market. The companies have utilized organic strategies (such as launches, expansion, and product approvals) and inorganic strategies (such as product launches, partnerships, and collaborations).